ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Pierre and Marie Curie University
París, FranciaPublicaciones en colaboración con investigadores/as de Pierre and Marie Curie University (3)
2022
-
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
The Lancet Oncology, Vol. 23, Núm. 5, pp. 659-670
-
Rationale and design of the PROMETCO study: A real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective
Future Oncology, Vol. 18, Núm. 11, pp. 1313-1320
2021
-
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
Annals of Oncology, Vol. 32, Núm. 5, pp. 600-608